UF Health Researcher, Collaborators Share $1.2 Million International Award for Vision Treatment (UF Health)

University of Florida Health ophthalmology researcher William Hauswirth, Ph.D. and his collaborators are sharing in a $1.2 million international award for developing a sight-restoring treatment for people who have a genetic form of vision loss.

The 2018 Antonio Champalimaud Vision Award recognizes Hauswirth and his colleagues for developing the first successful gene therapy to cure an inherited human disease. The disease, Leber congenital amaurosis Type 2, or LCA 2, is caused by a genetic defect. The 1 million euro (approximately $1.2 million) award from the Portugal-based D. Anna de Sommer Champalimaud and Dr. Carlos Montez Champalimaud Foundation is shared with University of Pennsylvania and University College of London researchers.

Learn more about UF Health Researcher, Collaborators Share $1.2 Million International Award for Vision Treatment.